Skip to search.
 BSE Up 0.19% NSE Up 0.28%
Streaming
Ticker Tape: On

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.04 Up 0.04(0.50%) 18 May 1:30AM|After Hours : 8.01 Down 0.03 (0.37%) 18 May 2:14AM

Add to Portfolio
Prev Close:8.00
Open:8.11
Bid:7.58 x 2000
Ask:8.74 x 100
1y Target Est:12.44
Beta:3.43
Next Earnings Date: 5-Aug-13KERX Earnings announcement
Day's Range:7.92 - 8.15
52wk Range:1.55 - 9.98
Volume:1,726,147
Avg Vol (3m):2,982,590
Market Cap:656.71M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KERX at this time.

Comparison

Symbol% ChgMkt Cap
KERXUp 0.50%656.71M
PFZ.L 0.00%173.71B
GSK.LUp 0.29%82.95B
AZN.LDown 0.45%42.18B
JNJ.MXUp 0.01%3.00T
» More Competitors

Key Statistics

Forward P/E (1 yr):100.50
P/S (ttm):93.35
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.32
Quarterly EPS Est (Jun-13) :-0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback